Xtant Medical Holdings Inc (XTNT)
0.4147
0.00 (0.00%)
USD |
NYAM |
Nov 21, 16:00
0.4107
0.00 (0.00%)
After-Hours: 20:00
Xtant Medical Holdings Enterprise Value: 85.83M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 85.83M |
| November 20, 2024 | 85.45M |
| November 19, 2024 | 88.23M |
| November 18, 2024 | 87.81M |
| November 15, 2024 | 87.87M |
| November 14, 2024 | 90.58M |
| November 13, 2024 | 93.29M |
| November 12, 2024 | 103.24M |
| November 11, 2024 | 100.30M |
| November 08, 2024 | 101.23M |
| November 07, 2024 | 101.85M |
| November 06, 2024 | 101.85M |
| November 05, 2024 | 101.83M |
| November 04, 2024 | 102.12M |
| November 01, 2024 | 102.25M |
| October 31, 2024 | 103.93M |
| October 30, 2024 | 102.51M |
| October 29, 2024 | 105.29M |
| October 28, 2024 | 103.14M |
| October 25, 2024 | 102.65M |
| October 24, 2024 | 102.26M |
| October 23, 2024 | 103.58M |
| October 22, 2024 | 104.48M |
| October 21, 2024 | 104.45M |
| October 18, 2024 | 104.61M |
| Date | Value |
|---|---|
| October 17, 2024 | 109.17M |
| October 16, 2024 | 107.53M |
| October 15, 2024 | 110.14M |
| October 14, 2024 | 110.83M |
| October 11, 2024 | 111.65M |
| October 10, 2024 | 110.44M |
| October 09, 2024 | 111.42M |
| October 08, 2024 | 117.77M |
| October 07, 2024 | 118.32M |
| October 04, 2024 | 115.55M |
| October 03, 2024 | 115.83M |
| October 02, 2024 | 117.63M |
| October 01, 2024 | 117.63M |
| September 30, 2024 | 121.93M |
| September 27, 2024 | 121.23M |
| September 26, 2024 | 121.91M |
| September 25, 2024 | 122.68M |
| September 24, 2024 | 121.98M |
| September 23, 2024 | 130.94M |
| September 20, 2024 | 125.73M |
| September 19, 2024 | 107.08M |
| September 18, 2024 | 104.79M |
| September 17, 2024 | 107.72M |
| September 16, 2024 | 110.89M |
| September 13, 2024 | 108.26M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
39.25M
Minimum
Jun 24 2022
389.90M
Maximum
Feb 26 2021
108.35M
Average
94.29M
Median
May 22 2020
Enterprise Value Benchmarks
| Plus Therapeutics Inc | 5.580M |
| Perspective Therapeutics Inc | -63.40M |
| Retractable Technologies Inc | -17.27M |
| InfuSystems Holdings Inc | 224.07M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.024M |
| Revenue (Quarterly) | 27.94M |
| Total Expenses (Quarterly) | 31.71M |
| EPS Diluted (Quarterly) | -0.04 |
| Gross Profit Margin (Quarterly) | 58.37% |
| Profit Margin (Quarterly) | -17.98% |
| Earnings Yield | -31.35% |
| Normalized Earnings Yield | -32.81 |